Market Price

25.96 

-0.36 -1.4%

as of Apr 18 '19

52 Week Range:

19.92 31.80


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians worldwide. It operates through European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development segments. The company offers various endocrinology, dermatology, analgesia and anesthesia, cardiovascular, and critical care products for dogs and cats; water soluble antibiotics, poultry vaccines, and locomotion and pain management products for poultry, pigs, and cattle; and lameness and pain management products for horses and ponies. It also provides pet nutrition products for dogs and cats under the Specific brand; distributes veterinary pharmaceuticals and equipment; and offers financial services. The company markets its products through wholesaler and distributor networks. Dechra Pharmaceuticals PLC was incorporated in 1997 and is headquartered in Northwich, the United Kingdom.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Jun '08 Jun '09 Jun '10 Jun '11 Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18
Equity (BVPS) 1.00
1.12
1.18
1.34
1.11
1.84
2.33
2.31
2.19
3.07
3.06
growth rate 12.0% 5.4% 13.6% -17.2% 65.8% 26.6% -0.9% -5.2% 40.2% -0.3%
Earnings BIT 11.71
16.10
17.73
18.51
16.82
21.00
25.58
26.44
32.69
40.20
45.10
growth rate 37.5% 10.1% 4.4% -9.1% 24.9% 21.8% 3.4% 23.6% 23.0% 12.2%
Avg.PE 29.76
24.69
19.34
23.04
31.15
55.56
32.68
0.44
56.52
129.15
57.94
growth rate -17.0% -21.7% 19.1% 35.2% 78.4% -41.2% -98.7% 12,745.5% 128.5% -55.1%
ROA 5.55
5.58
6.43
5.94
3.48
4.37
16.50
6.56
2.97
4.36
4.36
growth rate 0.5% 15.2% -7.6% -41.4% 25.6% 277.6% -60.2% -54.7% 46.8% 0.0%
ROE 16.26
14.83
15.77
15.32
9.32
10.91
31.12
9.75
5.40
9.07
8.96
growth rate -8.8% 6.3% -2.9% -39.2% 17.1% 185.2% -68.7% -44.6% 68.0% -1.2%
ROIC 12.09
10.78
12.05
11.30
6.27
6.37
22.47
8.40
3.85
5.69
5.63
growth rate -10.8% 11.8% -6.2% -44.5% 1.6% 252.8% -62.6% -54.2% 47.8% -1.1%
Cur. Ratio 1.18
1.24
1.32
1.55
1.56
1.73
2.42
2.46
2.45
2.79
2.71
growth rate 5.1% 6.5% 17.4% 0.7% 10.9% 39.9% 1.7% -0.4% 13.9% -2.9%
Quick Ratio 0.78
0.85
0.91
1.07
1.00
0.58
1.59
1.74
1.63
1.93
1.76
growth rate 9.0% 7.1% 17.6% -6.5% -42.0% 174.1% 9.4% -6.3% 18.4% -8.8%
Leverage 2.81
2.52
2.38
2.75
2.63
2.38
1.47
1.50
2.04
2.12
2.01
growth rate -10.3% -5.6% 15.6% -4.4% -9.5% -38.2% 2.0% 36.0% 3.9% -5.2%
Balance Sheet Jun '08 Jun '09 Jun '10 Jun '11 Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18
Acct.Receivable 43.70
45.00
48.30
65.00
71.00
26.00
29.18
28.97
67.32
65.20
79.00
growth rate 3.0% 7.3% 34.6% 9.2% -63.4% 12.2% -0.7% 132.3% -3.1% 21.2%
Acct.Payable 63.00
64.00
12.00
12.87
10.37
24.33
21.40
33.00
growth rate 1.6% -81.3% 7.2% -19.4% 134.6% -12.0% 54.2%
Cur.Assets 102.10
106.10
117.50
138.00
162.00
179.00
86.33
108.62
162.39
185.00
247.90
growth rate 3.9% 10.7% 17.5% 17.4% 10.5% -51.8% 25.8% 49.5% 13.9% 34.0%
Total Assets 201.80
203.70
205.50
270.00
404.00
415.00
300.77
293.53
555.83
638.10
1,017.30
growth rate 0.9% 0.9% 31.4% 49.6% 2.7% -27.5% -2.4% 89.4% 14.8% 59.4%
Cash 22.22
26.80
31.50
30.00
32.00
33.00
26.77
45.95
39.14
61.20
79.70
growth rate 20.6% 17.5% -4.8% 6.7% 3.1% -18.9% 71.6% -14.8% 56.4% 30.2%
Inventory 32.44
31.50
34.80
41.00
57.00
29.00
29.67
31.74
54.38
56.50
86.60
growth rate -2.9% 10.5% 17.8% 39.0% -49.1% 2.3% 7.0% 71.3% 3.9% 53.3%
Cur.Liabilities 86.60
85.70
89.00
89.00
103.00
104.00
35.72
44.11
65.98
66.40
91.60
growth rate -1.0% 3.9% 0.0% 15.7% 1.0% -65.7% 23.5% 49.6% 0.6% 38.0%
Liabilities 130.00
123.00
119.30
172.00
251.00
241.00
95.97
99.04
279.22
335.50
512.30
growth rate -5.4% -3.0% 44.2% 45.9% -4.0% -60.2% 3.2% 181.9% 20.2% 52.7%
LT Debt 28.00
23.10
17.80
56.00
114.00
104.00
31.65
32.52
154.09
180.20
289.90
growth rate -17.5% -22.9% 214.6% 103.6% -8.8% -69.6% 2.7% 373.9% 16.9% 60.9%
Equity 71.80
80.70
86.20
98.30
153.70
174.60
204.81
194.49
274.63
301.00
505.00
growth rate 12.4% 6.8% 14.0% 56.4% 13.6% 17.3% -5.0% 41.2% 9.6% 67.8%
Common Shares 65.00
73.00
73.00
72.00
75.00
88.00
88.00
88.00
90.00
93.00
97.00
growth rate 12.3% 0.0% -1.4% 4.2% 17.3% 0.0% 0.0% 2.3% 3.3% 4.3%
Cash Flow Statement Jun '08 Jun '09 Jun '10 Jun '11 Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18
Capital Expenditures 2.12
3.60
2.70
1.00
2.00
4.00
4.93
2.08
2.80
4.20
4.90
growth rate 69.8% -25.0% -63.0% 100.0% 100.0% 23.2% -57.8% 34.7% 49.9% 16.7%
Cash Dividends 4.42
5.60
6.20
7.20
8.30
11.20
12.58
13.86
15.29
17.70
21.80
growth rate 26.7% 10.7% 16.1% 15.3% 34.9% 12.3% 10.2% 10.4% 15.8% 23.2%
Cash From OA 8.56
20.30
17.30
17.00
19.00
37.00
11.47
40.98
43.58
77.40
64.00
growth rate 137.2% -14.8% -1.7% 11.8% 94.7% -69.0% 257.2% 6.3% 77.6% -17.3%
FCF per Share 0.10
0.23
0.20
0.17
0.17
0.20
0.18
0.41
0.41
0.58
0.67
growth rate 130.0% -13.0% -15.0% 0.0% 17.7% -10.0% 127.8% 0.0% 41.5% 15.5%
Sale Purchase of Stock 0.95
0.38
47.70
0.93
growth rate -60.5% 12,619.2% -98.1%
FCF 6.00
17.00
15.00
13.00
11.00
28.00
4.00
37.00
36.00
67.00
51.00
growth rate 183.3% -11.8% -13.3% -15.4% 154.6% -85.7% 825.0% -2.7% 86.1% -23.9%
Income Statement Jun '08 Jun '09 Jun '10 Jun '11 Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18
Sales 304.40
350.00
369.40
389.00
124.00
189.00
193.57
203.48
247.56
359.30
407.10
growth rate 15.0% 5.5% 5.3% -68.1% 52.4% 2.4% 5.1% 21.7% 45.1% 13.3%
Op.Income 14.07
17.67
19.87
14.00
4.00
21.00
25.58
26.44
32.69
40.20
45.10
growth rate 25.6% 12.5% -29.5% -71.4% 425.0% 21.8% 3.4% 23.6% 23.0% 12.2%
IBT 11.71
16.10
17.70
18.50
6.10
12.50
21.44
25.81
14.55
28.60
28.90
growth rate 37.5% 9.9% 4.5% -67.0% 104.9% 71.5% 20.4% -43.6% 96.6% 1.1%
Net Income 8.30
11.30
13.20
14.00
4.00
18.00
59.05
19.46
12.67
26.10
36.10
growth rate 36.1% 16.8% 6.1% -71.4% 350.0% 228.0% -67.0% -34.9% 106.0% 38.3%
EPS 0.13
0.16
0.18
0.20
0.15
0.20
0.67
0.22
0.14
0.28
0.37
growth rate 23.1% 12.5% 11.1% -25.0% 33.3% 235.0% -67.2% -36.4% 100.0% 32.1%
Gross Profit 53.60
73.70
80.60
88.00
71.00
101.00
107.71
116.14
138.51
195.90
227.50
growth rate 37.5% 9.4% 9.2% -19.3% 42.3% 6.6% 7.8% 19.3% 41.4% 16.1%
R&D 8.25
8.67
10.36
26.40
26.30
growth rate 5.1% 19.4% 155.0% -0.4%

Quarterly Statements

Item Name Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Earnings BIT 13.14
9.41
9.41
8.40
8.40
growth rate -28.3% 0.0% -10.8% 0.0%
Balance Sheet Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Acct.Receivable 68.13
79.00
79.00
77.70
77.70
growth rate 16.0% 0.0% -1.7% 0.0%
Acct.Payable 63.06
33.00
33.00
84.00
84.00
growth rate -47.7% 0.0% 154.6% 0.0%
Cur.Assets 208.22
247.90
247.90
262.00
262.00
growth rate 19.1% 0.0% 5.7% 0.0%
Total Assets 636.23
1,017.30
1,017.30
1,046.20
1,046.20
growth rate 59.9% 0.0% 2.8% 0.0%
Cash 75.82
79.70
79.70
86.90
86.90
growth rate 5.1% 0.0% 9.0% 0.0%
Inventory 64.27
86.60
86.60
97.40
97.40
growth rate 34.7% 0.0% 12.5% 0.0%
Cur.Liabilities 70.10
91.60
91.60
104.30
104.30
growth rate 30.7% 0.0% 13.9% 0.0%
Liabilities 320.94
512.30
512.30
542.10
542.10
growth rate 59.6% 0.0% 5.8% 0.0%
LT Debt 173.36
289.90
289.90
315.40
315.40
growth rate 67.2% 0.0% 8.8% 0.0%
Equity 313.74
505.00
505.00
504.10
504.10
growth rate 61.0% 0.0% -0.2% 0.0%
Common Shares 0.94
1.00
1.00
1.00
1.00
growth rate 7.0% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Capital Expenditures 1.20
1.25
1.25
3.35
3.35
growth rate 4.1% 0.0% 168.1% 0.0%
Cash Dividends 7.16
3.74
3.74
9.30
9.30
growth rate -47.7% 0.0% 148.5% 0.0%
Cash From OA 19.45
12.55
12.55
28.10
28.10
growth rate -35.5% 0.0% 123.9% 0.0%
Sale Purchase of Stock 0.36
growth rate
FCF 18.25
11.30
11.30
24.75
24.75
growth rate -38.1% 0.0% 119.0% 0.0%
Income Statement Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Sales 97.07
106.48
106.48
115.70
115.70
growth rate 9.7% 0.0% 8.7% 0.0%
Op.Income 13.14
9.41
9.41
8.40
8.40
growth rate -28.3% 0.0% -10.8% 0.0%
IBT 9.49
4.96
4.96
4.50
4.50
growth rate -47.8% 0.0% -9.2% 0.0%
Net Income 13.44
4.61
4.61
7.75
7.75
growth rate -65.7% 0.0% 68.1% 0.0%
Gross Profit 54.10
59.65
59.65
65.70
65.70
growth rate 10.3% 0.0% 10.1% 0.0%
R&D 6.27
6.88
6.88
7.70
7.70
growth rate 9.7% 0.0% 11.9% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

B (77.92)

YOY Growth Grade:

D (47.72)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 108.35 107.27 0.27
EPS / Growth 11.5% 0.24 17.0%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 30.7%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 11.5% 19.7% 19.7%
Future PE 0.27 19.85 19.85
Future EPS 0.72 1.46 1.46
Value Price
MOS %
0.05
-99.8%
7.18
-72.3%
7.18
-72.3%
MOS Price 0.02 3.59 3.59
IRT 22.90 16.24 16.24

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.